Natera
Michael Lin currently serves as the Vice President of Laboratory Operations at Natera since January 2019 and has been a Co-Founder of Dahlia Biosciences since June 2017. Previous experience includes independent consulting for Biotech from September 2016 to November 2017, and a role as Vice President of Operations at Transcriptic from July 2015 to August 2016. Additionally, Michael Lin worked in Operations and Business Continuity at Invitae for a brief period in late 2014, held the position of Product Manager in Production Genomics at Fluidigm Corporation from September 2010 to November 2014, was an Associate Scientist at the Immune Tolerance Institute from 2009 to July 2011, and served as a Senior Research Associate at Genitope Corp from 2000 to 2008. Michael Lin's educational background includes attendance at UCLA.
Natera
25 followers
Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology. Where some set out to build a test, they set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.